Efficacy of Transurethral Resection of the Bladder Tumor (TUR-BT) for Huge Bladder Cancer

Author:

Hamasaki Tsutomu1,Suzuki Yasutomo1,Tomita Yuji1,Kimura Go1,Kondo Yukihiro1

Affiliation:

1. Department of Urologic Surgery, Graduate School of Medicine, Nippon Medical School

Publisher

Medical Association of Nippon Medical School

Subject

General Medicine

Reference15 articles.

1. Chemoradiotherapy as a bladder-preservation approach for muscle-invasive bladder cancer: current status and perspectives

2. 2. Mersenburger AS, Matuschek I, Kuczyk MS: Bladder preserving strategies for muscle-invasive bladder cancer. Curr Opin Urol 2008; 18: 513-518.

3. 3. Babjuk M, Oosterlinck W, Sylvester R, Kassinen E, Bohle A, Palou J: Guidelines on TaT1 (non-muscle invasion) Bladder Cancer. European Association of Urology 2009. http://www.uroweb.org/fileadmin/tx_eauguidelines/2009/Full/TaT1_BC.pdf

4. 4. Tillou X, Gardel E, Fourmarier M, et al.: Can MRI used to distinguish between superficial and invasive transitional cell bladder cancer? Prog Urol 2008; 18: 440-444.

5. 5. EI-Assmy A, Abou-EI-Ghar ME, Mosbah A, et al.: Bladder tumor staging: comparison of diffusion- and T2-weighted MR imaging. Eur Radiol 2009; 19: 1575-1581.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3